Correlation Between Elevation Oncology and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Elevation Oncology and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Sonnet Biotherapeutics.
Diversification Opportunities for Elevation Oncology and Sonnet Biotherapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Elevation and Sonnet is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Elevation Oncology and Sonnet Biotherapeutics
Given the investment horizon of 90 days Elevation Oncology is expected to generate 1.31 times more return on investment than Sonnet Biotherapeutics. However, Elevation Oncology is 1.31 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.05 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.57 per unit of risk. If you would invest 60.00 in Elevation Oncology on August 31, 2024 and sell it today you would earn a total of 2.00 from holding Elevation Oncology or generate 3.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Elevation Oncology vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Elevation Oncology |
| Sonnet Biotherapeutics |
Elevation Oncology and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevation Oncology and Sonnet Biotherapeutics
The main advantage of trading using opposite Elevation Oncology and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Elevation Oncology vs. Cue Biopharma | Elevation Oncology vs. Eliem Therapeutics | Elevation Oncology vs. Inhibrx | Elevation Oncology vs. Molecular Partners AG |
| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |